Invesco
SVA

Invesco’s Sinovac Biotech, Ltd SVA Stock Holding History

Invesco’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-81,265
Closed -$619K – 3991
2018
Q3 		$619K Buy
81,265
+60,342
+288% +$435K ﹤0.01% 3342
2018
Q2 		$156K Sell
20,923
-86,248
-80% -$678K ﹤0.01% 3740
2018
Q1 		$923K Buy
+107,171
New +$883K ﹤0.01% 3062
2017
Q3 		– Sell
-109,967
Closed -$742K – 3745
2017
Q2 		$742K Buy
109,967
+10,881
+11% +$59.6K ﹤0.01% 3178
2017
Q1 		$568K Sell
99,086
-423
-0.4% -$2.45K ﹤0.01% 3283
2016
Q4 		$587K Sell
99,509
-14,579
-13% -$87.7K ﹤0.01% 3235
2016
Q3 		$673K Buy
114,088
+43
+0% +$253 ﹤0.01% 3138
2016
Q2 		$676K Buy
114,045
+8,081
+8% +$49.5K ﹤0.01% 3102
2016
Q1 		$677K Sell
105,964
-697
-0.7% -$4.18K ﹤0.01% 3102
2015
Q4 		$610K Buy
106,661
+18,211
+21% +$98K ﹤0.01% 3176
2015
Q3 		$449K Sell
88,450
-8,711
-9% -$46.1K ﹤0.01% 3286
2015
Q2 		$510K Sell
97,161
-19,381
-17% -$102K ﹤0.01% 3383
2015
Q1 		$578K Sell
116,542
-27,190
-19% -$134K ﹤0.01% 3290
2014
Q4 		$752K Sell
143,732
-57,403
-29% -$293K ﹤0.01% 3110
2014
Q3 		$967K Buy
201,135
+26,880
+15% +$144K ﹤0.01% 2992
2014
Q2 		$983K Sell
174,255
-6,197
-3% -$37.6K ﹤0.01% 3020
2014
Q1 		$1.3M Sell
180,452
-49,296
-21% -$326K ﹤0.01% 2867
2013
Q4 		$1.41M Sell
229,748
-9,418
-4% -$56.7K ﹤0.01% 2887
2013
Q3 		$1.43M Buy
239,166
+31,678
+15% +$151K ﹤0.01% 2787
2013
Q2 		$815K Buy
+207,488
New +$772K ﹤0.01% 3014

Other funds holding SVA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSP
Sapphire Star Partners Redmond, Washington $74.7M AUM 5.87% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Invesco's SVA Position: Q4 2018 in Review

Invesco sold out of Sinovac Biotech, Ltd (SVA) in Q4 2018, closing a stake of 81,265 shares — an estimated $619K sold.

Invesco first reported a position in SVA in Q2 2013 and held it in 20 quarters. The position peaked at $1.43M in Q3 2013. 27 funds tracked by Wall St. Rank hold SVA as of Q4 2018.

  • Invesco reported no remaining Sinovac Biotech, Ltd position as of Q4 2018 after selling out during the quarter.
  • Invesco sold 81,265 Sinovac Biotech, Ltd shares in Q4 2018, an estimated $619K.
  • Invesco first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 20 quarters.
  • Invesco's Sinovac Biotech, Ltd position peaked at $1.43M in Q3 2013.
  • 27 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2018.

Based on Invesco's 13F filing for Q4 2018, filed 14 Feb 2019.